Delivery Order SPE2DB22D3501-SPE2DB25FWM74
- Not listed
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $966 to Amerisourcebergen Drug Corporation. The order is for 4561557398 Ramelteon 8 mg tablets to be delivered within a one-day period ending July 21, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. No additional details were provided regarding the original solicitation, any set aside designations, or involvement of major subcontractors. The...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred fifteen thousand six hundred sixty-eight dollars to Amerisourcebergen Drug Corporation for the supply of thirty boxes of eight milligram ramelteon tablets. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from September 6 to September 7, 2023. As a leading provider of pharmaceuticals and medical supplies to the Department of...
- The Defense Logistics Agency awarded a $29,160 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 8 mg Ramelteon tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 21-24, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical supplies and pharmaceuticals are...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,122 to Amerisourcebergen Drug Corporation. The order is for 30 packages of 8mg Ramelteon tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this order placed against an existing DLA contract vehicle. No set aside designation or...
- The Defense Logistics Agency awarded a $596.88 delivery order to Amerisourcebergen Drug Corporation for the provision of 30 Ramelteon 8 mg tablets. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will fulfill the order from its place of performance in Conshohocken, Pennsylvania under a firm fixed price arrangement. The order is funded by the Defense Logistics Agency and has a period of performance spanning August 21, 2023 through August 22, 2023. No set...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,305 to Amerisourcebergen Drug Corporation for the supply of 100 boxes containing 8 mg tablets of ramelteon. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 6, 2023. Amerisourcebergen Drug Corporation is a division of Amerisourcebergen Corporation, which will perform as the prime contractor for this requirement supporting the Defense Logistics...
- This federal contract award, valued at $1,801.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,062,698 units of the prescription medication ramelteon 8 mg tablet, with an ultimate completion date of April 29, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA...
- This delivery order for $349 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for 30 tablets of 8 mg ramelteon. The order is for product delivery by October 18, 2023 under a firm fixed price contract. Amerisourcebergen Drug Corp will perform the order from its location in Conshohocken, Pennsylvania. No set-aside provision was specified for this order placed under an existing vehicle by the Defense Logistics Agency to fulfill pharmaceutical needs for the military.
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has a firm fixed price of $2,197.83 and a period of performance through August 14, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a wide range of...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWM74Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and runs through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal medical procurement needs. The Ramelteon order exemplifies the company's role in fulfilling pharmaceutical requirements across the Defense Health Agency and broader military healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 7/21/25 |